WallStreetZenWallStreetZen

NASDAQ: CDT
Conduit Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Conduit Pharmaceuticals earnings were -$17.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CDT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.4M, down 62.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CDT reported annual earnings of -$17.8M, with 3,227.5% growth.

CDT earnings history

Current Revenue
$0.0
Current Earnings
-$17.8M
Current Profit Margin
0%

CDT Return on Equity

Insufficient data to display

CDT undefined

Current Company
-462.1%
Current Industry
-0.4%
CDT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CDT announces earnings.

CDT undefined

Current Company
248.87%
Current Industry
5.9%
CDT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CDT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CDT-$15.75M-$17.80MN/A-$20.53
TOVX-$25.06M-$25.65MN/A-$19.03
INM-$6.98M-$7.91MN/A-$13.75
XBIO-$3.96M-$3.96MN/A-$2.57
TCRT-$4.68M-$4.68MN/A-$2.92
View Top Biotech Stocks

Conduit Pharmaceuticals Earnings Reports & History FAQ

What were Conduit Pharmaceuticals's earnings last quarter?

Conduit Pharmaceuticals (NASDAQ: CDT) reported Q4 2024 earnings per share (EPS) of -$0.53, up 352.38% year over year. Total CDT earnings for the quarter were -$2.41 million. In the same quarter last year, Conduit Pharmaceuticals's earnings per share (EPS) was $0.21.

If you're new to stock investing, here's how to buy Conduit Pharmaceuticals stock.

Is Conduit Pharmaceuticals profitable or losing money?

As of the last Conduit Pharmaceuticals earnings report, Conduit Pharmaceuticals is currently losing money. Conduit Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$17.80 million, a 3,227.48% increase year over year.

What was CDT's earnings growth in the past year?

As of Conduit Pharmaceuticals's earnings date in Q2 2025, Conduit Pharmaceuticals's earnings has grown year over year. CDT earnings in the past year totalled -$17.80 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.